All In Biotech

Drug Trial Radar · NCT05114096

Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)

Single Dose of Antenatal Corticosteroids (SNACS) Randomized Controlled Trial for Pregnancies at Risk of Preterm Delivery: To Keep Babies and Children Safe

Last checked: Nov 19, 2026Latest source record: Jan 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 3,254 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

3,254

Planned (sponsor's estimate)

Start

Jul 20, 2023

Primary completion

Dec 31, 2026

Study completion Dec 31, 2029

Sponsor

Lead sponsor
McMaster UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Hamilton Health Sciences Corporation; Sunnybrook Research Institute; Women's and Children's Hospital, Australia; Canadian Institutes of Health Research (CIHR); Medical Research Future Fund; University of Adelaide
First posted
Nov 9, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Other
FDA-regulated drug
No
Who can join
Female only, from 18 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Antenatal corticosteroids (ACS) reduce the risks of neonatal death and morbidities in preterm infants, such as respiratory distress syndrome. The standard of care for pregnant people at risk of preterm birth includes 2 doses of Celestone (for a total of 24 mg in Canada, or 22.8 mg in Australia) to accelerate fetal lung maturity. The investigators plan to conduct a randomized controlled trial to determine whether half the usual dose (12 mg in Canada, or 11.4 mg in Australia) of Celestone is non-inferior to the standard double doses.

Conditions

  • Preterm Birth
  • Premature Birth
  • Complication of Prematurity
  • Obstetric Labor, Premature
  • Pregnancy Complications

Interventions

  • Celestone + placeboDrug

    After the first intramuscular injection of Celestone, participants randomized to the "Placebo Comparator" group will receive 1 intramuscular injection of placebo.

  • Celestone + CelestoneDrug

    After the first intramuscular injection of Celestone, participants randomized to the "Active Comparator" group will receive 1 intramuscular injection of Celestone.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Perinatal Mortality or Substantial Neonatal MorbidityTime frame: approximately 1 month

Locations

25 sites in 1 country. Site status is shown where the registry gives one.

  • University of Calgary, Cumming School of Medicine

    Calgary, Alberta, Canada · Recruiting

  • Alberta Health Services; University of Alberta

    Edmonton, Alberta, Canada · Recruiting

  • Royal Columbian Hospital

    New Westminster, British Columbia, Canada · Not yet recruiting

  • Fraser Health, University of British Columbia; Jim Pattison Outpatient Care and Surgery Centre

    Surrey, British Columbia, Canada · Not yet recruiting

  • University of British Columbia; BC Women's Hospital

    Vancouver, British Columbia, Canada · Not yet recruiting

  • Victoria General Hospital

    Victoria, British Columbia, Canada · Not yet recruiting

  • University of Manitoba, Health Sciences Centre

    Winnipeg, Manitoba, Canada · Not yet recruiting

  • University of Manitoba; St. Boniface General Hospital

    Winnipeg, Manitoba, Canada · Not yet recruiting

  • Dr. Everett Chalmers Regional Hospital

    Fredericton, New Brunswick, Canada · Recruiting

  • The Moncton Hospital, Horizon Health Network

    Moncton, New Brunswick, Canada · Recruiting

  • Memorial University, Eastern Health

    St. John's, Newfoundland and Labrador, Canada · Not yet recruiting

  • Dalhousie University; Izaak Walton Killam Health

    Halifax, Nova Scotia, Canada · Recruiting

  • McMaster University

    Hamilton, Ontario, Canada · Recruiting

  • Queen's University, Kingston General Hospital Health Sciences Centre

    Kingston, Ontario, Canada · Recruiting

  • Western University; London Health Sciences Centre, Victoria Hospital

    London, Ontario, Canada · Recruiting

  • University of Ottawa; The Ottawa Hospital

    Ottawa, Ontario, Canada · Recruiting

  • Mount Sinai Hospital

    Toronto, Ontario, Canada · Recruiting

  • Sunnybrook Health Sciences Center

    Toronto, Ontario, Canada · Recruiting

  • Hopital Maisonneuve Rosemont, CIUSSS de l'est de l'Ile de Montréal

    Montreal, Quebec, Canada · Recruiting

  • McGill University, McGill University Health Center, Royal Victoria Hospital

    Montreal, Quebec, Canada · Recruiting

  • Sir Mortimer B. Davis Jewish General Hospital; McGill University

    Montreal, Quebec, Canada · Not yet recruiting

  • The Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal

    Montreal, Quebec, Canada · Recruiting

  • Université Laval, Centre de recherche du CHU de Québec

    Québec, Quebec, Canada · Recruiting

  • (CIUSSS de l'Estrie-CHUS); Université de Sherbrooke

    Sherbrooke, Quebec, Canada · Recruiting

  • University of Saskatchewan, Regina General Hospital

    Saskatoon, Saskatchewan, Canada · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.